-
1Academic Journal
Alternate Title: Análisis coste-utilidad de venetoclax en combinación con obinutuzumab como tratamiento de primera línea de la leucemia linfocítica crónica en España (Spanish; Castilian)
Authors: Moreno-Martínez, Estela, de la Serna-Torraba, Javier, Escudero-Vilaplana, Vicente, Hernández-Rivas, José Ángel, Sánchez-Cuervo, Marina, Sánchez-Hernández, Raquel *
Source: In Farmacia Hospitalaria May-June 2022 46(3):121-132
-
2Academic Journal
Authors: Ojeda, Isabel Muñoz1 munozisabel@hotmail.co.uk, Sánchez-Cuervo, Marina2, Candela-Toha, Ángel3, Serrano-López, Dolores R.4, Bermejo-Vicedo, Teresa5, Alcaide-López-de-Lerma, Juan Miguel6
Source: Critical Care Nurse. Aug2023, Vol. 43 Issue 4, p30-38. 9p. 1 Diagram, 2 Charts.
Subject Terms: *MEDICATION error prevention, *INTENSIVE care units, *MEDICAL quality control, *PROPOFOL, *ANALGESIA, *ANESTHESIA, *INTRAVENOUS therapy, *MEDICAL technology, *MEDICATION errors, *FENTANYL, *CONTINUING education units, *DRUG infusion pumps, *MORPHINE, *IMIDAZOLES, *DRUG administration, *TREATMENT effectiveness, *CRITICAL care medicine, *QUALITY assurance, *REMIFENTANIL, *MIDAZOLAM, *PATIENT safety, *PAIN management
-
3Academic Journal
Authors: Quesada Muñoz, Lucía, Fernández-Fradejas, Jorge, Martinez-Barros, Hilario, Sánchez Cuervo, Marina, Rufo, Miriam Martín, Pintor Recuenco, Maria del Rosario, Rodríguez-Navarro, Carmen Quereda, Álvarez-Díaz, Ana María, Saez de la Fuente, Javier
Source: European Journal of Hospital Pharmacy; Nov2024, Vol. 31 Issue 6, p532-536, 5p
-
4Academic Journal
Alternate Title: Impacto de la protocolización de mezclas intravenosas de fármacos vasoactivos en el coste del tratamiento del paciente crítico (Spanish; Castilian)
Authors: Cuesta-López, Isabel *, Sánchez-Cuervo, Marina, Candela-Toha, Ángel, Benedí-González, Juana, Bermejo-Vicedo, Teresa
Source: In Farmacia Hospitalaria March 2018 42(2):62-67
-
5Academic Journal
Alternate Title: Cost-utility analysis of venetoclax in combination with obinutuzumab as first-line treatment of chronic lymphocytic leukaemia in Spain. (English)
Authors: Moreno-Martínez, Estela, la Serna-Torroba, Javier de, Escudero-Vilaplana, Vicente, Hernández-Rivas, José Ángel, Sánchez-Cuervo, Marina, Sánchez-Hernández, Raquel
Source: Farmacia Hospitalaria (1130-6343); May/Jun2022, Vol. 46 Issue 3, p121-132, 12p
-
6Academic Journal
Authors: Pueyo-López, Cristina1 cristina.pueyo@salud.madrid.org, Sánchez-Cuervo, Marina1, Vélez-Díaz-Pallarés, Manuel1, Ortega-Hernández-Agero, Teresa2, Salazar-López de Silanes, Esther Gómez de1
Source: Journal of Oncology Pharmacy Practice. Oct2021, Vol. 27 Issue 7, p1588-1595. 8p.
-
7Academic Journal
Authors: Sánchez-Cuervo, Marina, García-Basas, Lorena, Gómez de Salazar-López de Silanes, Esther, Pueyo-López, Cristina, Bermejo-Vicedo, Teresa
Source: American Journal of Hospice & Palliative Medicine; Aug2020, Vol. 37 Issue 8, p641-647, 7p
-
8Academic Journal
Alternate Title: Evaluation of adherence and clinical outcomes in patients undergoing allogeneic haematopoietic stem cell transplantation. (English)
Authors: García-Basas, Lorena, Sánchez-Cuervo, Marina, de Salazar-López de Silanes, Esther Gómez, Pueyo-López, Cristina, Núñez-Torrón-Stock, Claudia, Herrera-Puente, Pilar
Source: Farmacia Hospitalaria (1130-6343); may/jun2020, Vol. 44 Issue 3, p87-91, 5p
-
9Academic Journal
Alternate Title: Impact of the implementation of vasoactive drug protocols on costs in the treatment of critically ill patients. (English)
Authors: Cuesta-López, Isabel, Sánchez-Cuervo, Marina, Candela-Toha, Ángel, Benedí-González, Juana, Bermejo-Vicedo, Teresa
Source: Farmacia Hospitalaria (1130-6343); mar/abr2018, Vol. 42 Issue 2, p62-67, 6p